Slough Estates PLC
SLOUGH ESTATES plc
SLOUGH ESTATES TO DEVELOP 780,000 SQ.FT. CAMPUS FOR GENENTECH IN CALIFORNIA
Slough Estates plc, a leading provider of flexible business space, today
announced that Genentech, Inc. (NYSE: DNA) has agreed to terms with Slough
Estates USA Inc to lease approximately 780,000 square feet of office and
laboratory space in eight new buildings on its Britannia East Grand site, South
San Francisco. Genentech proposes to integrate the development with its existing
campus in South San Francisco.
Slough's construction will take place in two phases over a four-year period and
is estimated to cost over $325 million.
The master-planned campus project will be funded from the proceeds of selective
asset sales by Slough Estates USA Inc., which is now established as a
self-financing part of the Group.
Genentech is a leading biotechnology company that discovers, develops,
manufactures and commercializes biotherapeutics for significant unmet medical
needs.
Ian Coull, Chief Executive of Slough Estates commented: 'We believe the lease
agreement with Genentech to extend their campus onto our Britannia East Grand
site reinforces Slough's position as the pre-eminent developer and brand leader
of life sciences facilities in California. We have a successful history of
working with our clients to deliver a market-leading product in the rapidly
expanding life sciences industry. Our strategy to recycle assets selectively to
fund further development evidences Slough Estates' commitment to delivering
maximum shareholder value from our asset portfolio.'
For further information contact:
Slough Estates plc Shared Value Limited
Ian Coull, Chief Executive Andrew Best / Emily Bruning
Tel: 01753 537171 Tel: 020 7321 5022 / 5027
Slough Estates is a leading provider of flexible business space in business
parks in Western Europe and North America, with over 1700 customers occupying
2.9 million square metres of business space, with a total value of £3.6 billion.
Slough Estates' properties are in suburban locations in close proximity to the
main business centres, where there is long-term demand for business
accommodation to serve these key economic regions. The company's main activities
are currently based around London, Brussels, Paris, Düsseldorf, San Francisco
and San Diego and the company continues to develop new business parks with the
long term objective of building shareholder value and enhancing its reputation
for quality buildings offering excellent value to customers.
An interview with Ian Coull in video/audio and text will be available from 07:00
on: www.sloughestates.com and on http://www.cantos.com
A conference call for analysts / investors is being held at 09:30 today and is
accessible on: +44 (0)20 7019 9526 or at:
http://investor.sloughestates.com/medialist.cfm
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.